Tenders Are Invited For 27/21 Antitumor Drugs. Immunosuppressants

Medicine Octreotide Por-K For Preparations. Suspensions for I/M Introduction to the Set. With R-Lem, Vial Adapter, 10 Mg Injection Needle,Medicine Octreotide Por-K For Preparations. Suspensions for I/M Introduction to the Set. With R-Lem, Vial Adapter, 20 Mg Injection Needle,Medicine Octreotide Por-K For Preparations. Suspensions for I/M Introduction to the Set. With R-Lem, Vial Adapter, 30 Mg Injection Needle,Medicine Octreotide RR For Injection (For IV and SC Administration) (RR For Infusion AND SC Administration) 100 µg/ml 1 ml,Medicine Octreotide RR For Injection (For IV and SC Administration) 50 µg/ml 1 ml,Drug Methylprednisolone Lyophilized Por-K (Lyophilisate) For Preparations. Solution for Injection In Set. With R-Lem 1000 mg,Medicine Methylprednisolone Tablets 16 Mg,Medicine Methylprednisolone Tablets 32 Mg,Medicine Methylprednisolone Tablets 4 Mg,Medicine Interferon Alpha 2B RR For Injection (Lyophilisate) 3 Million IU/Ml,Medicine Vedolizumab Por-K (Lyophilisate) For Preparations. Concentrate For Preparations. Solution for Infusion 300 Mg,Medicine Infliximab Lyophilized Por-K (Lyophilisate) For Preparation. Concentrate For Preparations. Solution for IV Administration (For Infusion) 100 Mg,Medicine Levilimab R-R For SC Administration (For Infusions AND SC Administration) 180 Mg/Ml 0.9 Ml,Medicine Leflunomide Tablets P/O 20 Mg,Drug Netakimab R-R SC Administration 60 Mg/Ml,Medicine Tocilizumab Concentrate for Preparation of Solution for Infusion 20 Mg/Ml 10 Ml,Medicine Tocilizumab Concentrate for Preparation of Solution for Infusion 20 Mg/Ml 20 Ml,Medicine Tocilizumab Concentrate for Preparation of Solution for Infusion 20 Mg/Ml 4 Ml,Medicine Tocilizumab R-R For SC Administration 162 Mg 0.9 Ml,Medicine Eculizumab Concentrate For Preparation. Solution of Infusion 10 Mg/Ml 30 Ml,1,2